Navigation Links
The Academy of Radiology Research featured in Nature Biotechnology journal
Date:6/9/2014

The Academy of Radiology Research reported in the current issue of Nature Biotechnology (Volume 32, Issue 6) that patent output from the National Institutes of Health (NIH) is vital to understanding which various areas of science are contributing most to America's innovation economy. The report, "Patents as Proxies: NIH Hubs of Innovation," confirms an increased economic value of NIH patents as compared to private sector patents, as well as meaningful differences in the rate and quality of invention across different research and development (R&D) investments.

"The Academy of Radiology Research undertook this analysis to address a need from the Office of Management and Budget (OMB) and the Office of Science and Technology Policy (OSTP) to develop econometric evidence to better guide federal R&D budgets," said Michael Kalutkiewicz, co-author of the report and senior director for government affairs at the Academy of Radiology Research. "Looking at the NIH as a whole, the results demonstrate that the quality of NIH's scientific discoveries can't be replicated by the private sector alone. However, when we look across the agency, the data also reveal meaningful differences in patent productivity and downstream economic impact between various areas of NIH-funded research."

Patents are widely-accepted as being vital to growing America's innovation economy, and the U.S. Congress and the White House have been taking steps to strengthen America's patent system. There is also a nascent movement, fueled by both the congress and the administration, to improve how the impacts of federal spending are measured in an effort to guide R&D investments.

According to the report, patents generated by NIH-funded research are of particularly high quality and provide a downstream economic footprint that exceeds comparable research funded by the private sector. On average, NIH patents provide the intellectual foundation for 8 additional downstream patents, while biotechnology patents created by private sector entities only spur 1.7 future patents over a similar time period.

"The report in Nature Biotechnology provides empirical evidence that NIH-funded discoveries not only fuel a high level of additional R&D activity, but also that the scientific base for the nation's innovation economy would be significantly diminished without publicly-funded research," said Renee Cruea, MPA, Executive Director of the Academy of Radiology Research.

The report also showed that budget size did not correlate to a higher rate of new inventions. The strongest producer of new intellectual property (IP) was the National Institute for Biomedical Imaging and Bioengineering (NIBIB), the most recent Institute created by Congress and having one of the smallest operating budgets within NIH. Other strong producers were the National Institute of General Medical Sciences (NIGMS), the National Institute of Dental and Craniofacial Research (NIDCR), the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Eye Institute (NEI) and the National Cancer Institute (NCI).

Over the last 10 years, NIBIB researchers have created 16 patents for every $100 million in research dollars, compared to 2.4 patents for every $100 million in NIH funding from other institutes. This equates to a cost of just $6 million for each imaging research patent compared to $39 million for one patent in other areas of research. Since patents lead to higher rates of new technologies, companies and jobs, imaging and bioengineering science results in the greatest economic impact from public research funds.

"The traditional scientific criteria that guide the way that we prioritize investments in medical research are important and time-tested," said Richard Ehman, MD, the report's co-author and president of the Society of Body Computed Tomography and Magnetic Resonance Imaging (SBCTMR). "But rates of invention and related outcome measures deserve to be considered as criteria that can help to identify areas of science such as in imaging research that demonstrate a strong return-on-investment."

The metrics examined in this report are receiving more attention from policymakers and other stakeholders, particularly in light of growing calls for the development of better evidenced-based budgeting in federal science programs.

"We in the science community should do more to satisfy the public interest in quantifying the impact of federally-funded medical research," said Cruea. "This study is a step towards evidence-based budgeting that satisfies the dual aim of translation to patient care and downstream economic development."

"This study underscores the far-reaching impact of robust public-private collaboration in biomedical imaging and bioengineering research," said Michael Harsh, vice president and chief technology officer for GE Healthcare. "American medical innovation relies in part on industry R&D coming alongside NIH, NIBIB, academia and clinical researchers to help increase quality, access and affordability in the healthcare space. Industry innovation leaders, like GE Healthcare, see value in this continuing collaboration as we look to bring groundbreaking discoveries to the clinical setting which ultimately impacts patient care."

Given the importance of hard data to reinforce the value of federal funding to NIH, the Academy is finalizing a follow-on analysis that looks at patent output through a number of additional metrics, such as by mechanism and study section.


'/>"/>

Contact: Roxanne Yaghoubi
roxanne@acadrad.org
202-347-5872
Academy of Radiology Research
Source:Eurekalert

Related medicine news :

1. Clinical news alert from the American Academy of Orthopaedic Surgeons
2. Hutchinson Center president elected to American Academy of Art and Sciences
3. First recipients of AcademyHealths Presidential Scholarship announced
4. UT MD Anderson President Ronald DePinho elected to National Academy of Sciences
5. Clinical news alert: Journal of the American Academy of Orthopaedic Surgeons May highlights
6. Snoring Isn't Sexy Member Dr. Mark Levy attends Academy of Clinical Sleep Disorders Disciplines Conference in Phoenix, Arizona
7. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
8. Leading health care quality expert is 2012 AcademyHealth Distinguished Investigator
9. American Academy of Family Physicians joins AmericanEHR Partners
10. Wolters Kluwer Health and the American Academy of Neurology renew partnership
11. Cell Phones and Brain Cancer: American Academy of Pediatrics Endorses Cell Phone Right to Know Act, Bernstein Liebhard LLP Reports
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2017)... ... ... The Los Angeles leg of the US movie premier of the Man in the Camo ... the Clive Davis Theater inside the Grammy Museum Located in downtown Los Angeles in the ... Welsh rock musician, Mike Peters (of The Alarm), his rise to fame, battle with cancer ...
(Date:7/27/2017)... ... 27, 2017 , ... Cremations recently surpassed traditional burials for the first time ... expected to continue with over 70% of Americans projected to choose cremation by 2030. ... that enable families to celebrate the life of a lost loved one in different ...
(Date:7/26/2017)... ... ... greater Bay Area roller derby leagues are partnering with Brown Paper Tickets and the American ... blood drives in California, beginning July 29. Make ‘Em Bleed roller derby blood drives have ... have helped to save up to 2700 lives. , “The Make ‘Em Bleed blood drives ...
(Date:7/26/2017)... Maryland (PRWEB) , ... July ... ... Society for Pharmaceutical Engineering (ISPE) will host its 2017 Process Validation ... These concurrent events offer comprehensive solutions to process validation lifecycle challenges faced ...
(Date:7/26/2017)... (PRWEB) , ... July 26, 2017 , ... ... dogs and cats has opened in Jupiter. The state of the art ... and class leading treatments with a goal of providing heart patients longer lives. ...
Breaking Medicine News(10 mins):
(Date:7/25/2017)... and CAMBRIDGE, Massachusetts , July 25, ... in repurposing drugs to treat rare nervous system diseases, has ... clinically develop and market the drug SOM0226 against transthyretin amyloidosis ... achieved very promising results in a Phase 2 study conducted ... new office in the United States ...
(Date:7/21/2017)... and RESEARCH TRIANGLE PARK, N.C. ... (NASDAQ: UTHR ) announced today that it ... the market opens on Thursday, July 27, 2017. ... a teleconference on Thursday, July 27, 2017, at 9:00 ... 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of ...
(Date:7/17/2017)... Fla. , July 17, 2017  MedX Holdings, ... branded medical testing, strengthening and rehabilitation equipment, today announced ... Machine Program. MedX is considered the gold standard for ... leader in specialized medical strengthening equipment. ... a lease with the physician or practice who prescribe ...
Breaking Medicine Technology: